| PMID |
18397603 ( ![]() ![]() ![]() ) |
|---|---|
| Title | Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model. |
| Abstract | OBJECTIVE: The functional connection between muscle and nerve is often altered in several neuromuscular diseases, including amyotrophic lateral sclerosis (ALS). Knowledge about the molecular and cellular mechanisms involved in the restorative reactions is important to our understanding of the processes involved in neuromuscular maintenance. We previously reported that muscle-restricted expression of a localized Igf-1 isoform maintained muscle integrity, stabilized neuromuscular junctions, reduced inflammation in the spinal cord and enhanced motor neuronal survival in SOD(G93A) mice, delaying the onset and progression of the disease. In this study, we analysed potential molecular pathways that are modulated by mIgf-1 to counteract muscle wasting and to preserve motor neurons activity. METHODS: We performed molecular and morphologic analysis to address the specific proposed questions. RESULTS AND DISCUSSION: Ubiquitin expression and caspase activity resulted markedly increased in SOD(G93A) muscle but maintained at very low levels in the SOD(G93A) x MLC/mIgf-1 (SOD(G93A)/mIgf-1) transgenic muscle. In addition, CDK5 expression, a serine-threonine protein kinase that has been implicated in a number of physiologic processes in nerve and muscle cells, was reduced in SOD(G93A) muscle but increased in SOD(G93A)/mIgf-1 muscle. Notably, while the toxic p25 protein accumulated in SOD(G93A) muscle, no accumulation was evident in the SOD(G93A)/mIgf-1 muscle. The maintenance of muscle phenotype was also associated with maintenance of a normal peripheral nerve, and a greater number of myelinated axons. CONCLUSION: These observations offer novel insights into the role of mIgf-1 in the attenuation of muscle wasting in the mouse model of ALS disease. IIM, University of Rome La Sapienza, Via A. Scarpa, 14 Rome 00161, Italy. |
NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.
Targets by SciMiner Summary
| HUGO ID | Symbol | Target Name | #Occur | ActualStr |
|---|---|---|---|---|
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 8 | SOD | |
| 10417 | RPS27A | ribosomal protein S27a | 2 | ubiquitin | |
| 1774 | CDK5 | cyclin-dependent kinase 5 | 2 | CDK5 | |
| 24594 | DCTN5 | dynactin 5 (p25) | 1 | p25 | |
| 17082 | MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 | 1 | MLC | |
Targets by SciMiner Full list
| HUGO ID | Symbol | Name | ActualStr | Score | FlankingText |
|---|---|---|---|---|---|
| 1774 | CDK5 | cyclin-dependent kinase 5 | CDK5 | 0.3 | Local expression of mIgf-1 modulates ubiquitin caspase and CDK5 expression in skeletal muscle of an ALS mouse model |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | the spinal cord and enhanced motor neuronal survival in SOD(G93A) SOD G93A mice delaying the onset and progression of the disease |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | Ubiquitin expression and caspase activity resulted markedly increased in SOD(G93A) SOD G93A muscle but maintained at very low levels in the |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | muscle but maintained at very low levels in the SOD(G93A) SOD G93A x MLC/mIgf-1 MLC mIgf-1 (SOD(G93A)/mIgf-1) SOD G93A mIgf-1 transgenic |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | in the SOD(G93A) SOD G93A x MLC/mIgf-1 MLC mIgf-1 (SOD(G93A)/mIgf-1) SOD G93A mIgf-1 transgenic muscle |
| 17082 | MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 | MLC | 0.3 | very low levels in the SOD(G93A) SOD G93A x MLC/mIgf-1 MLC mIgf-1 (SOD(G93A)/mIgf-1) SOD G93A mIgf-1 transgenic muscle |
| 1774 | CDK5 | cyclin-dependent kinase 5 | CDK5 | 0.3 | In addition CDK5 expression a serine-threonine protein kinase that has been implicated in |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | processes in nerve and muscle cells was reduced in SOD(G93A) SOD G93A muscle but increased in SOD(G93A)/mIgf-1 SOD G93A mIgf-1 muscle |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | reduced in SOD(G93A) SOD G93A muscle but increased in SOD(G93A)/mIgf-1 SOD G93A mIgf-1 muscle |
| 24594 | DCTN5 | dynactin 5 (p25) | p25 | 0.8 | Notably while the toxic p25 protein accumulated in SOD(G93A) SOD G93A muscle no accumulation was |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | Notably while the toxic p25 protein accumulated in SOD(G93A) SOD G93A muscle no accumulation was evident in the SOD(G93A)/mIgf-1 SOD |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 0.8 | SOD G93A muscle no accumulation was evident in the SOD(G93A)/mIgf-1 SOD G93A mIgf-1 muscle |
| 10417 | RPS27A | ribosomal protein S27a | ubiquitin | 1.0 | local expression of migf 1 modulates ubiquitin caspase and cdk5 expression in skeletal muscle of an als mouse model. |
| 10417 | RPS27A | ribosomal protein S27a | ubiquitin | 1.0 | results and discussion: ubiquitin expression and caspase activity resulted markedly increased in sod g93a muscle but maintained at very low levels in the sod g93a x mlc/migf 1 sod g93a /migf 1 transgenic muscle. |